HealthPort, a supplier of revenue cycle management solutions, has merged with IOD, which offers document management, denial management and other services.
Consumer-directed health plan administrative services vendor Alegeus releases results of a survey showing that members in that plan design were much more likely to know the details of their coverage and to research cost and quality data on providers and treatments.
According to research in Health Affairs false positive mammograms cost $4 billion in unnecessary spending, leading to concerns about the adequacy of current screening.
Private equity firm Abry is buying Sentry Data Systems, a provider of health system software for compliance, security and procurement, apparently for over $200 million.
Evolent Health, a "population health" company, has filed for an IPO to raise $100 million. The company lost $52 million last year so I guess this is a new way to value firms. Now tell me that this isn't absurd.
Health IT security vendor Imprivata has acquired HT Systems, which offers a palm-vein identification system, for around $20 million. The deal was done on a handshake.
Truveris' National Drug Index shows that drug unit prices continue their rapid ascent in 2015, rising 3.8% in the first quarter, led by brand price growth of 5.7%.
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at khroche@healthy-skeptic.com.
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at khroche@healthy-skeptic.com.